Resource centre

Bibliography
News & insights
Whitepapers, publications & posters
Upcoming events & webinars
Webinar recordings

News & insights
22 October 2025
Bringing Trial Activities to the Participant - Lessons from the RADIAL Proof-of-Concept Trial
Read more
21 October 2025
Speech Analysis as an Objective Biomarker in MDD Trials Speech Biomarkers for Alzheimer’s Disease Show Promise Across Multiple Languages
Read more
13 October 2025
CTAD | Posters & Presentations
Read more
13 October 2025
DIS | Posters & Presentations
Read more
09 October 2025
Closing the Gap - Speech Analysis as an Objective Biomarker in MDD Trials
Read more
30 September 2025
CTIS | Posters & Presentations
Read more
25 September 2025
ISCTM and ECNP | Posters & Presentations
Read more
11 September 2025
How Picture Description Tasks Can Help Track Cognitive Health Remotely
Read more
19 August 2025
Cambridge Cognition Investment, Monument Therapeutics, Announces Partnership with Foundation for the National Institutes of Health for Clinical Trial of MT1988, a Novel Treatment for Schizophrenia
Read more
18 August 2025
Cognition in The Blood (Biomarker)
Read more
12 August 2025
Cambridge Cognition launches Speaker Identification Solution to Safeguard Clinical Trial Integrity  
Read more
31 July 2025
Trading update for period ended 30 June 2025
Read more
25 June 2025
AAIC25 | Posters & Presentations
Read more
24 June 2025
Cambridge Cognition Investment, Monument Therapeutics, Achieves Positive Phase I Results for Novel Schizophrenia Treatment
Read more
01 May 2025
SIRS 2025: Insights on Schizophrenia Research, From Rights Based Care to Digital Biomarkers
Read more
17 April 2025
Monument Therapeutics Announces Appointment of Robert Radie as Chair and Heather Preston to Advisory Board
Read more
11 April 2025
Dementias Platform UK: TRANSLATIONS 2025
Read more
11 April 2025
When to Use Standardised Assessments—And When You Might Need to Build Your Own
Read more
10 April 2025
Cambridge Cognition Secures £1million Contract for Phase 3 Autoimmune Disease Trial
Read more
03 April 2025
Cambridge Cognition selected for two Phase 3 trials combining digital cognitive and voice solutions 
Read more
Find more of our insights

Whitepapers, publications & posters
22 October 2025
Bringing Trial Activities to the Participant - Lessons from the RADIAL Proof-of-Concept Trial
21 October 2025
Speech Analysis as an Objective Biomarker in MDD Trials Speech Biomarkers for Alzheimer’s Disease Show Promise Across Multiple Languages
13 October 2025
CTAD | Posters & Presentations
13 October 2025
DIS | Posters & Presentations
09 October 2025
Closing the Gap - Speech Analysis as an Objective Biomarker in MDD Trials
30 September 2025
CTIS | Posters & Presentations
25 September 2025
ISCTM and ECNP | Posters & Presentations
11 September 2025
How Picture Description Tasks Can Help Track Cognitive Health Remotely
18 August 2025
Cognition in The Blood (Biomarker)
25 June 2025
AAIC25 | Posters & Presentations
01 May 2025
SIRS 2025: Insights on Schizophrenia Research, From Rights Based Care to Digital Biomarkers
11 April 2025
When to Use Standardised Assessments—And When You Might Need to Build Your Own
14 March 2025
SIRS 2025 | Posters & Presentations
11 March 2025
AD/PD 2025 | Posters & Presentations
11 March 2025
Actigraphy and wearable sensor technologies to enhance assessment in health conditions
28 January 2025
ISCTM 2025
06 January 2025
Enhancing Patient Outcomes in ADRD: Digital Measures that Matter
19 November 2024
Exploring Innovation in Alzheimer's Disease Research: Highlights from CTAD 2024
01 November 2024
CTAD24 | Posters & Content
29 October 2024
CTAD24 | Clinical Trials on Alzheimer's Disease
18 October 2024
Clinical Trials Innovation Summit 2024
14 September 2024
ISCTM 2024: Analytical validation of a novel quality assurance approach for COAs in Alzheimer’s Disease clinical trials
05 March 2024
Digital measures to advance research & quality of life in schizophrenia
01 March 2024
Prediction of mental effort derived from an automated vocal biomarker using machine learning in a large-scale remote sample
22 June 2023
Evaluating the utility of daily speech assessments for monitoring depression symptoms
25 May 2023
Frontiers in Neurology | Revolutionising the detection of cognitive impairment in multiple sclerosis with technology
25 May 2023
Frontiers in Psychiatry | Using affective cognition to enhance precision psychiatry
25 May 2023
CANTAB Mobile: experience of use of a digital memory screening tool in primary care
28 November 2017
Neuroscience & Biobehavioral Reviews | Social cognition: an important but overlooked aspect of cognitive function

eBooks & whitepapers

Upcoming events

Find more events

Webinar recordings
26 October 2023
Success Factors for Remote and Hybrid Decentralised Trials from Site, Technology and Service Provider Perspectives with a Focus on the RADIAL Study from Trials@Home
31 May 2023
Monitoring fluctuations in psychiatric symptoms though analysis of speech
31 May 2023
Speech analytics and natural language processing for automation of quality assurance in clinical trials
31 May 2023
Speech biomarkers from active and passive collection of voice in Alzhiemer’s disease clinical trials
29 September 2022
Real-World Measurement of Cognition and Mood in Frontline COVID-19 Healthcare Workers
12 April 2022
Successful Statistical Strategies for Patient Screening and Stratification
11 November 2021
Decentralised Trials in Psychiatry: From Feasibility to Novel Insights
29 October 2021
Novel Digital Technologies and Biomarkers to Characterise Depression
21 October 2021
Digital Health Event 2021: Integrating multimodal data to meet clinical challenges
07 July 2021
Voice Technology in Clinical Trials
16 October 2020
Virtual clinical trials: What have we learned in the era of Covid-19?
29 September 2020
Remote Cognitive Testing and Lessons Learned During Lockdown
18 September 2020
Wearable Technology for High-Frequency Cognitive and Mood Assessments in Depression
01 June 2020
Elderly patients in clinical trials: addressing the evidence-practice gap
12 February 2020
Future directions in eCOA: Innovations in high-frequency and automated voice-based testing
02 January 2020
Pro-cognitive drug trial failures in schizophrenia: the need for cognitive screening?
07 June 2019
Cognitive Safety: Satisfying Regulatory Requirements in a Competitive Landscape
24 October 2018
Digital Health: Optimizing Clinical Trials with Patient-Centric Technology
25 May 2018
Early Alzheimer’s Disease: Finding the Right Patients for Clinical Trials and Beyond
06 February 2018
Schizophrenia Trials: Overcoming Methodological Challenges to Enhance Study Success
23 March 2017
Leveraging Cognitive Measures in Clinical Trials
23 March 2017
Understanding the Clinical Assessment of Abuse Potential during CNS Drug Development
23 March 2017
Assessing Cognitive Safety of Drugs in Clinical Development
Cambridge Cognition
Scroll to Top